Propofol, amobarbital… is it the substance that matters, or the question about the role of the Wada test in brain tumor patients?
Contributors
Schaller, Karl LothardPublished in
World neurosurgery, vol. 75, no. 3-4, p. 428-430Publication date
2011Keywords
- Amobarbital/adverse effects/diagnostic use
- Anesthesia, Intravenous
- Anesthetics, Intravenous/adverse effects/diagnostic use
- Brain Neoplasms/surgery
- Epilepsy/diagnosis/surgery
- Hemispherectomy
- Humans
- Hypnotics and Sedatives/adverse effects/diagnostic use
- Language
- Neuropsychological Tests
- Neurosurgical Procedures
- Postoperative Complications/diagnosis
- Predictive Value of Tests
- Prognosis
- Propofol/adverse effects/diagnostic use
- Speech/physiology
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
SCHALLER, Karl Lothard. Propofol, amobarbital… is it the substance that matters, or the question about the role of the Wada test in brain tumor patients? In: World neurosurgery, 2011, vol. 75, n° 3-4, p. 428–430. doi: 10.1016/j.wneu.2010.11.037
Main files (1)
Article (Published version)
Identifiers
- PID : unige:46419
- DOI : 10.1016/j.wneu.2010.11.037
- PMID : 21600484
